CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Randomised Phase I/II trial assessing the safety and efficacy of radiolabelled anti-carcinoembryonic antigen I131 KAb201 antibodies given intra-arterially or intravenously in patients with unresectable pancreatic adenocarcinoma
Author
A Goel
A Jemal
+51Â more
A Sultana
Asma Sultana
Catrin Tudur Smith
Conall Garvey
D Cunningham
D Gold
D Goldenberg
D Goldenberg
D Goldenberg
D Parkin
F Grunert
F Kraeber-Bodere
G Adams
G Colucci
G Hajjar
G Ritter
H Burris
H Reiss
Investigator brochure
J Kelsey
J Osborne
JD Berlin
John P Neoptolemos
Jonathan E Evans
JY Mabrut
K Aigner
K Engelhardt
K Yamaguchi
Lorraine Bosonnet
M Juweid
Michael GT Raraty
MJ Moore
N Kemeny
N Oriuchi
P Therasse
Paula Ghaneh
R Hermann
R Jain
R Reilly
Robert Sutton
S Benchimol
S Shore
S Vinjamuri
Seema Chauhan
Sobhan Vinjamuri
Steven Lane
Susannah Shore
T Behr
T Behr
TM Behr
V Heinemann
Publication venue
BioMed Central
Publication date
25/02/2009
Field of study
Get PDF
Crossref
Springer - Publisher Connector
PubMed Central